ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)
JPY 2041.0
(-0.34%)
JPY 2041.0
(-0.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 93.31 Billion JPY | 7.09% |
| 2022 | 87.13 Billion JPY | 4.61% |
| 2021 | 83.29 Billion JPY | 0.87% |
| 2020 | 82.58 Billion JPY | 2.92% |
| 2019 | 80.23 Billion JPY | -2.38% |
| 2018 | 82.19 Billion JPY | 24.09% |
| 2017 | 66.23 Billion JPY | 0.16% |
| 2016 | 66.12 Billion JPY | 15.05% |
| 2015 | 57.47 Billion JPY | -2.47% |
| 2014 | 58.93 Billion JPY | 14.95% |
| 2013 | 51.26 Billion JPY | -0.97% |
| 2012 | 51.77 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 87.32 Billion JPY | -6.42% |
| 2024 Q2 | 88.26 Billion JPY | 1.08% |
| 2023 Q2 | 91.92 Billion JPY | 3.09% |
| 2023 FY | 93.31 Billion JPY | 7.09% |
| 2023 Q4 | 93.31 Billion JPY | -1.63% |
| 2023 Q3 | 94.85 Billion JPY | 3.2% |
| 2023 Q1 | 89.16 Billion JPY | 2.33% |
| 2022 Q3 | 90.79 Billion JPY | 5.3% |
| 2022 Q4 | 87.13 Billion JPY | -4.03% |
| 2022 FY | 87.13 Billion JPY | 4.61% |
| 2022 Q1 | 84.76 Billion JPY | 1.76% |
| 2022 Q2 | 86.22 Billion JPY | 1.73% |
| 2021 FY | 83.29 Billion JPY | 0.87% |
| 2021 Q3 | 87.53 Billion JPY | 11.8% |
| 2021 Q1 | 81.71 Billion JPY | -1.05% |
| 2021 Q4 | 83.29 Billion JPY | -4.84% |
| 2021 Q2 | 78.29 Billion JPY | -4.19% |
| 2020 Q2 | 79.44 Billion JPY | -0.9% |
| 2020 FY | 82.58 Billion JPY | 2.92% |
| 2020 Q4 | 82.58 Billion JPY | -1.15% |
| 2020 Q1 | 80.16 Billion JPY | -0.09% |
| 2020 Q3 | 83.54 Billion JPY | 5.16% |
| 2019 Q2 | 82.76 Billion JPY | -1.77% |
| 2019 Q3 | 83.63 Billion JPY | 1.05% |
| 2019 FY | 80.23 Billion JPY | -2.38% |
| 2019 Q1 | 84.25 Billion JPY | 2.51% |
| 2019 Q4 | 80.23 Billion JPY | -4.07% |
| 2018 Q4 | 82.19 Billion JPY | 2.64% |
| 2018 Q2 | 82.83 Billion JPY | 9.05% |
| 2018 Q1 | 75.96 Billion JPY | 14.69% |
| 2018 FY | 82.19 Billion JPY | 24.09% |
| 2018 Q3 | 80.08 Billion JPY | -3.32% |
| 2017 Q1 | 67.08 Billion JPY | 1.45% |
| 2017 FY | 66.23 Billion JPY | 0.16% |
| 2017 Q4 | 66.23 Billion JPY | -3.11% |
| 2017 Q3 | 68.35 Billion JPY | 1.62% |
| 2017 Q2 | 67.26 Billion JPY | 0.27% |
| 2016 Q1 | 58.49 Billion JPY | 1.77% |
| 2016 FY | 66.12 Billion JPY | 15.05% |
| 2016 Q2 | 60.69 Billion JPY | 3.77% |
| 2016 Q4 | 66.12 Billion JPY | -0.41% |
| 2016 Q3 | 66.39 Billion JPY | 9.39% |
| 2015 Q2 | 57.76 Billion JPY | -0.08% |
| 2015 Q1 | 57.81 Billion JPY | -1.9% |
| 2015 Q4 | 57.47 Billion JPY | -5.23% |
| 2015 Q3 | 60.65 Billion JPY | 4.99% |
| 2015 FY | 57.47 Billion JPY | -2.47% |
| 2014 Q4 | 58.93 Billion JPY | 3.17% |
| 2014 Q2 | 57.2 Billion JPY | 6.71% |
| 2014 Q1 | 53.6 Billion JPY | 4.56% |
| 2014 Q3 | 57.12 Billion JPY | -0.14% |
| 2014 FY | 58.93 Billion JPY | 14.95% |
| 2013 FY | 51.26 Billion JPY | -0.97% |
| 2013 Q1 | 51.9 Billion JPY | 0.26% |
| 2013 Q3 | 52.99 Billion JPY | 0.89% |
| 2013 Q4 | 51.26 Billion JPY | -3.25% |
| 2013 Q2 | 52.52 Billion JPY | 1.19% |
| 2012 Q4 | 51.77 Billion JPY | -0.38% |
| 2012 Q3 | 51.96 Billion JPY | 3.65% |
| 2012 Q2 | 50.13 Billion JPY | 0.0% |
| 2012 FY | 51.77 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -155.139% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.382% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 89.718% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 93.414% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -505.095% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 64.575% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 45.63% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 93.305% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -443.048% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 71.619% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 41.239% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -22.04% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -88.326% |
| Tsumura & Co. | 428.25 Billion JPY | 78.211% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 64.239% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 30.068% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 78.332% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -9.352% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 38.013% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 47.483% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -520.178% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -20.08% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -507.815% |
| MedRx Co., Ltd | 2.05 Billion JPY | -4447.368% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -392.455% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -3559.294% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -4505.896% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 75.574% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -2113.908% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 87.935% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -191.563% |